Featured news in The Life Sciences Report



3D Signatures Inc. (DXD:TSX.V; TDSGF:OTCQB; 3D0:FSE)
3D Signatures Inc. Adds Medical Diagnostic Expert to Business Advisory Board (2/15/2017)

view
 


Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Prothena (PRTA) Reports Wider-than-Expected Loss in Q4 (2/15/2017)

view
 


Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Durable Responses and Sustained Low Disease Activity Over Nine Months After a Single Dose of Mesoblast Cell Therapy in Rheumatoid Arthritis Patients Resistant to Anti-TNF Agents (2/15/2017)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
City of Hope to Manufacture NurOwn® for Brainstorm's Phase 3 ALS Clinical Trial (2/16/2017)

view
 


Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
AMAG Pharma (AMAG) Incurs Loss in Q4, Revenues Lag Estimates (2/15/2017)

view
 


Athersys Inc. (ATHX:NASDAQ)
Athersys to Host Year-End 2016 Financial Results Call (2/14/2017)

view
 


Celgene Corp. (CELG:NASDAQ)
Amgen Looking to Broaden Leukemia Drug Blincyto's Label (2/15/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
Biotech Stock Roundup: Regeneron's Praluent to Remain on Market for Now, GILD Presents HIV Data (2/15/2017)

view
 


Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Acorda (ACOR) Reports Narrower-than-Expected Loss in Q4 (2/15/2017)

view
 


Cesca Therapeutics Inc. (KOOL:NASDAQ)
Cesca Therapeutics Reports Second Quarter Fiscal 2017 Financial Results and Provides Business Update (2/13/2017)

view
 


RXi Pharmaceuticals Corp. (RXII:NASDAQ)
RXi Pharmaceuticals Appoints Medical Oncology Expert, Dr. James Griffin, to Scientific Advisory Board (2/14/2017)

view
 


Inovio Pharmaceuticals Inc. (INO:NASDAQ)
Blog Coverage Inovio Inks Collaboration and License Deal with ApolloBio for Greater China (2/14/2017)

view